AirSculpt Technologies, Inc. (AIRS) vs Cryo-Cell International Inc. (CCEL)
- AirSculpt Technologies, Inc. AIRS 0.55 −61.81%
- Cryo-Cell International Inc. CCEL 4.97 +0.40%
AirSculpt Technologies, Inc. and Cryo-Cell International Inc. are both Medical Care Facilities companies. AirSculpt Technologies, Inc. is the larger, with a market value of $103.8M against $39.9M — 2.6× the size. Cryo-Cell International Inc. grew revenue faster over the last twelve months: −1.96% against −6.27%. AirSculpt Technologies, Inc. has the higher net margin (0.00% vs −6.25%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Cryo-Cell International Inc. leads on 10 and AirSculpt Technologies, Inc. on 6.
Valuation
Profitability
| Metric | AIRS | CCEL | Medical Care Facilities median |
|---|---|---|---|
| Gross margin | 0.00% | 78.54% | 30.56% |
| Operating margin | 0.00% | 0.61% | 6.62% |
| Net margin | 0.00% | (6.25%) | 3.08% |
| Free cash flow margin | (1.72%) | 14.94% | 7.22% |
| Return on equity | 0.00% | 12.46% | 6.41% |
| Return on assets | 0.00% | (3.10%) | 2.78% |
| Return on invested capital | 0.00% | 0.00% | 7.44% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack